How to assess pharmacogenomic tests for implementation in the NHS in England. (2023)
Attributed to:
Multimorbidity Mechanism and Therapeutics Research Collaborative
funded by
SPF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.15820
PubMed Identifier: 37313748
Publication URI: http://europepmc.org/abstract/MED/37313748
Type: Journal Article/Review
Volume: 89
Parent Publication: British journal of clinical pharmacology
Issue: 9
ISSN: 0306-5251